Conference abstract · 7 Dec 2015
Conference abstractPublished 18 May 2017
Plant made pharmaceuticals for developing countries
University of Toronto, Canada
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Plant made biologics have elicited much attention over recent years for their potential to assist those in developing countries who have poor access to modern medicine. Vaccines and other biopharmaceuticals derived from plants are inexpensive, lack refrigeration requirements and can be produced en masse in a relatively short period of time. Pharmaceuticals developed in this fashion could be utilized for functions ranging from defense against infectious diseases that have pandemic potential, such as influenza or Ebola virus, to combating orphan diseases which are poorly funded yet remain paramount to global health in their respective endemic regions. Biopharmaceuticals have been generated via a number of plant production platforms, including stable expression in transgenic plants, suspension cell cultures and hairy roots, as well as transiently through the use of plant virus expression vector technologies. The presentation will provide an overview of plant-derived pharmaceuticals and will conclude with a projection of the impact they could have for developing countries.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2021
Plant Virus Nanoparticles: New Applications for Developing Countries
Review article · 2013
Applications of Plant-derived Vaccines for Developing Countries
Editorial · 2012
Are Low- and Middle-Income Countries Repeating Mistakes Made by High-Income Countries in the Control of HIV for Men who have Sex with Men?
Article · 20 Jan 2025
Antimicrobial property of a potential bio-hand sanitizer made from Alugbati (Basella alba), Makahiya Plant (Mimosa pudica), and Mayana Plant (Coleus blumei)
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 14 Apr 2026
Ethiopian Child Immunization Coverage Prevalence and Determinants: Evidence from the 2019 Mini-Demographic and Health Survey
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Kathleen Hefferon”
